×
About 45 results

ALLMedicine™ Anagen Effluvium Center

Research & Reviews  15 results

Anagen Effluvium
https://emedicine.medscape.com/article/1073488-print

Apr 6th, 2021 - Background Normal human hairs can be classified according to the three phases of their growth cycle: anagen, catagen, and telogen. Anagen hairs are in a growing phase, during which the matrix cells of the hair follicle undergo vigorous mitotic act...

Anagen Effluvium
https://emedicine.medscape.com/article/1073488-overview

Apr 6th, 2021 - Background Normal human hairs can be classified according to the three phases of their growth cycle: anagen, catagen, and telogen. Anagen hairs are in a growing phase, during which the matrix cells of the hair follicle undergo vigorous mitotic act...

Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
https://www.mdedge.com/dermatology/article/237621/hair-nails
Christa Slaught, MD, Michael Roman, MD et. al.

Mar 24th, 2021 - Anagen effluvium during chemotherapy is common, typically beginning within 1 month of treatment onset and resolving by 6 months after the final course. 1 Permanent chemotherapy-induced alopecia (PCIA), in which hair loss persists beyond 6 months af.

Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744849
Dermatologic Therapy; Rizzetto G, Diotallevi F et. al.

Nov 16th, 2020 - Telogen effluvium (TE) is one of the most common form of hair loss in women. Many triggers have been identified, as stress, drugs, trauma, endocrine disease, nutritional deficiencies, and febrile states. We report three cases of TE occurred after ...

Cutaneous manifestations in pediatric oncology patients.
https://doi.org/10.1111/pde.14375
Pediatric Dermatology; Özkur E, Sert C et. al.

Nov 13th, 2020 - Oncology patients present with various skin manifestations related to primary disease and treatments. Although these skin toxicities are well described in adults, studies of pediatric oncology patients are limited. The objective of this study was ...

see more →

News  2 results

Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
https://www.mdedge.com/dermatology/article/237621/hair-nails
Christa Slaught, MD, Michael Roman, MD et. al.

Mar 24th, 2021 - Anagen effluvium during chemotherapy is common, typically beginning within 1 month of treatment onset and resolving by 6 months after the final course. 1 Permanent chemotherapy-induced alopecia (PCIA), in which hair loss persists beyond 6 months af.

Acute-Onset Alopecia
https://www.mdedge.com/dermatology/article/199906/hair-nails/acute-onset-alopecia?channel=113
Justin P. Bandino, MD, Dirk M. Elston, MD

Apr 30th, 2019 - The Diagnosis: Thallium-Induced Alopecia At the time of presentation, a punch biopsy specimen of the scalp revealed nonscarring alopecia with increased catagen hairs; follicular miniaturization; peribulbar lymphoid infiltrates; and fibrous tract r.

see more →

Patient Education  1 results see all →